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the complexity of the common ances-
tors of archaea (Csuros and Miklos, 
2009) and large eukaryotic viruses 
(Yutin et al., 2009). It seems that the 
evolution of major classes of life typi-
cally begins with a turbulent phase, 
which leads to the emergence of a 
highly complex ancestor. Specific lin-
eages then diverge from this common 
ancestor by one of three pathways: (1) 
genome streamlining, in which numer-
ous genes are lost, the genomes 
shrinks, and functional redundancy 
decreases; (2) genome stasis, in which 
limited amounts of genes are lost and 
gained at roughly the same rate via 
duplication and other processes; (3) 
genome expansion, in which the rate of 
gene acquisition substantially exceeds 
the rate of gene loss.
Comparative genomics of free-living 
unicellular eukaryotes such as Naegleria 
will help to develop more detailed and 
confident reconstructions of the gene 
repertoire of the last common ancestor 
of eukaryotes. However, understanding 
the processes that led to the emergence 
of complex common ancestors, particu-
larly for the eukaryotes, requires other 
approaches and is one of the most dif-
ficult and exciting challenges facing evo-
lutionary biologists today.
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Angelman syndrome is a neurodevelopmental disorder caused by mutations in the maternally 
inherited UBE3A gene, which encodes a ubiquitin ligase. Greer et al. (2010) now identify a UBE3A 
substrate called Arc that promotes endocytosis of neuronal AMPA receptors, providing insight into 
synaptic defects that may underlie the cognitive deficits in Angelman syndrome.Angelman syndrome is a neurodevel-
opmental disorder caused by lack of a 
functional maternal copy of the UBE3A 
gene, which encodes a ubiquitin ligase 
(reviewed in Dan, 2009). Its symptoms 
include developmental delay, mental 
retardation, excessive inappropriate 
laughter, movement ataxia, seizures, 
and lack of speech. Angelman syndrome 
is commonly caused by the microdele-
tion of chromosome region 15q11-q13, 
which contains UBE3A, and to a lesser 
extent by mutations in UBE3A. When 
the same region on the paternal allele 
is deleted, the result is a different disor-
der called Prader-Willi syndrome, char-
acterized by endocrine abnormalities, 608 Cell 140, March 5, 2010 ©2010 Elsevier obesity, temper tantrums, and milder 
mental retardation than in Angelman 
syndrome.
This interesting relationship between 
Angelman syndrome and Prader-Willi 
syndrome can be explained by the 
genomic imprinting of certain genes 
located on chromosome 15q11-q13. 
As a result of imprinting, some human 
brain regions express only the mater-
nally derived UBE3A, whereas most 
tissues express both parental alleles. 
The corresponding region on murine 
chromosome 7 is similarly imprinted. 
Mice show preferential expression of 
maternal Ube3a in the hippocampus 
and Purkinje cells of the cerebellum. Inc.The evolutionary significance of this 
imprinting and expression pattern is 
not yet understood. It has been rec-
ognized for more than a decade that 
Angelman syndrome results from the 
loss of UBE3A function in specific brain 
regions, but the underlying cause of the 
neurological defects is little understood 
in molecular terms. In this issue of Cell, 
Greer et al. (2010) report an important 
advance with their identification of a 
new role for UBE3A in the regulation of 
synaptic transmission.
UBE3A encodes an E3 ubiquitin 
protein ligase containing a C-terminal 
HECT domain that catalyzes the ubiq-
uitination of target proteins. Ubiquitin 
figure 1. UBe3A, Arc, and AMPAR endocytosis
Mutations in the UBE3A gene, which encodes an E3 ubiquitin ligase, are a cause of a neurodevelopmental disorder called Angelman syndrome.
(Left) A substrate of UBE3A in synapses, Arc, is transcribed rapidly after robust neuronal stimulation and promotes the internalization of AMPA-type glutamate 
receptors (AMPARs), resulting in a reduction in synaptic strength.
(Middle) Several hours after neuronal stimulation, newly synthesized UBE3A ubiquitinates Arc to promote its degradation by the proteasome, thus preventing 
further internalization of AMPARs.
(Right) A disruption in the function of UBE3A in neurons leads to increased expression of Arc and a decrease in AMPARs at excitatory synapses, which may 
contribute to the neurological symptoms of Angelman syndrome.is a small protein with 76 amino acids 
whose C terminus can be covalently 
linked to a protein’s lysine residues. The 
UBE3A protein, also called E6-associ-
ated protein or E6-AP, attaches a polyu-
biquitin chain to protein substrates and 
marks them for degradation by the pro-
teasome. Judging from UBE3A point 
mutations found in Angelman syndrome 
patients, this disease can be attributed 
to the loss of ligase function (Cooper et 
al., 2004). Furthermore, UBE3A local-
izes to synapses, and mice lacking the 
Ube3a gene show defects in synaptic 
plasticity and morphology (Dindot et 
al., 2008, Jiang, et al., 1998, Yashiro et 
al., 2009). Hence, the failure to degrade 
certain synaptic proteins is likely to 
contribute to symptoms of Angelman 
syndrome, such as developmental and 
cognitive impairments.
Major challenges in understanding 
UBE3A function include devising an 
unbiased method to identify its sub-
strates in neurons and deciphering its 
rule for substrate recognition. Greer and 
coworkers succeeded in tackling these 
issues head on by using a proteomics 
approach. First, they crossed hemag-
glutinin-tagged ubiquitin knockin mice 
with Ube3a knockout mice. By immu-
noprecipitating hemagglutinin-tagged 
ubiquitinated proteins and subjecting 
them to quantitative mass spectrometry, 
they identified proteins with decreased ubiquitination in the hippocampus of 
Ube3a knockout mice compared to wild-
type mice. Next, within these identified 
proteins a consensus recognition motif 
for UBE3A was discovered and verified. 
This represents major progress in our 
understanding of UBE3A’s function and 
provides a strategy to investigate other 
ubiquitin ligases.
Using the combination of mass spec-
trometry, bioinformatics, biochemical 
characterization, and Ube3a knockout 
mice, Greer and colleagues identified 
several new UBE3A targets, including 
Arc, RhoGEF, ephexin 5, and sacsin. Arc 
stands out as a target of interest because 
its importance in activity-dependent syn-
aptic regulation has been studied exten-
sively. The authors found that UBE3A 
prevents the internalization of AMPA-
type glutamate receptors (AMPARs) in 
synaptic membranes by targeting Arc for 
degradation (Figure 1).
Arc is a synaptic protein that inter-
acts with dynamin and endophilin and 
promotes the endocytosis of AMPARs 
(reviewed in Bramham et al., 2008). It 
is involved in several forms of synaptic 
plasticity, including long-term potentia-
tion, long-term depression, and homeo-
static scaling. Both its transcription and 
local translation in neuronal dendrites 
are dependent on synaptic activity. 
Greer et al. found that after robust syn-
aptic activation, both Arc and Ube3a Cell 1undergo MEF2-dependent transcrip-
tion. Arc transcription is turned on more 
quickly (?1 hr) than Ube3a transcription 
(?6 hr). At dendritic spines, newly syn-
thesized Arc promotes endocytosis of 
AMPARs, resulting in a reduction in syn-
aptic strength in response to excessive 
neuronal stimulation. The delayed induc-
tion of UBE3A helps to reduce Arc levels 
and prevents excessive AMPAR internal-
ization (Figure 1). In the hippocampus of 
Ube3a knockout mice, synaptic AMPAR 
levels are reduced, accompanied by 
defects in synaptic transmission. These 
findings suggest that experience-depen-
dent synaptic development and activity-
dependent synaptic regulation may be 
disrupted in Angelman syndrome.
The accumulation of Arc alone, how-
ever, probably cannot account for all of 
the symptoms of Angelman syndrome. 
Neuronal functions of other UBE3A tar-
gets are also worth exploring. Among the 
new targets found in this study, sacsin is 
also interesting because it is mutated in a 
neurodegenerative disorder called auto-
somal recessive spastic ataxia of Char-
levoix-Saguenay (ARSACS) (Takiyama, 
2007). Very little is understood about sac-
sin’s functions at this point. Furthermore, 
UBE3A has been found to copurify with 
26S proteasomes in HEK293 cells (Wang 
et al., 2007) and muscle (Besche et al., 
2009). Although mammalian genomes 
encode hundreds of E3 ubiquitin ligase 40, March 5, 2010 ©2010 Elsevier Inc. 609
enzymes, only a few appear to interact 
with the proteasome. Also, a number of 
deubiquitinating enzymes interact with 
the proteasome. It is possible that E3 
ubiquitin ligases and deubiquitinating 
enzymes associated with the proteasome 
can edit the ubiquitin chain as the sub-
strate approaches the proteasome. In this 
way, these enzymes can modulate sub-
strate specificity or alter the overall rate 
of protein degradation. If UBE3A turns 
out to be a component of neuronal or 
synaptic proteasomes, certain Angelman 
syndrome symptoms may also be related 
to altered proteasome composition in the 
affected neurons. This may represent 
an alternative model for understanding 
UBE3A function in the brain that counters 
the current notion that UBE3A is a freely 
diffusing E3 ubiquitin ligase with perhaps 
a dozen specific substrates.
Although recent advances in genom-
ics have allowed us to pinpoint the cause 
of hereditary neurological disorders like 610 Cell 140, March 5, 2010 ©2010 Elsevier
Robustness to genetic and environmen-
tal variation is an essential feature of all 
biological systems. In recent years, it has 
become possible to address the molecular 
mechanisms that ensure the reproducible 
outcomes of biological processes. These 
mechanisms often break down in mutant 
conditions, leading to variable outcomes. 
In genetic terms, penetrance refers to the 
proportion of individuals of a particular 
mutant genotype displaying a mutant phe-
notype. In a paper that recently appeared 
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In recent work published in Natu
show that variation in gene expre
incomplete penetrance. They fin
an upstream regulator crosses aAngelman syndrome to a single gene like 
UBE3A, it has proven difficult to under-
stand the functional consequences of the 
gene mutation or deletion. The same can 
be said for parkin, an E3 ubiquitin ligase 
linked to autosomal recessive juvenile 
Parkinsonism. This reflects our general 
lack of understanding about how the 
ubiquitin-proteasome system contrib-
utes to the maintenance and regulation 
of the neuronal proteome. A broad-scale 
approach, like that taken by Greer et al., 
can elucidate elements both upstream 
and downstream of the gene of interest, 
positioning the mutation in a functional 
synaptic context where the link to the 
disease may be clarified.
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